León-Cachón, R. B. R., Ascacio-Martínez, J. A., Gamino-Peña, M. E., Cerda-Flores, R. M., Meester, I., Gallardo-Blanco, H. L., . . . Barrera-Saldaña, H. A. (2016). A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers. BMC Cancer.
Παραπομπή Chicago StyleLeón-Cachón, Rafael B. R., Jorge A. Ascacio-Martínez, María E. Gamino-Peña, Ricardo M. Cerda-Flores, Irene Meester, Hugo L. Gallardo-Blanco, Magdalena Gómez-Silva, Everardo Piñeyro-Garza, και Hugo A. Barrera-Saldaña. "A Pharmacogenetic Pilot Study Reveals MTHFR, DRD3, and MDR1 Polymorphisms As Biomarker Candidates for Slow Atorvastatin Metabolizers." BMC Cancer 2016.
Παραπομπή MLALeón-Cachón, Rafael B. R., et al. "A Pharmacogenetic Pilot Study Reveals MTHFR, DRD3, and MDR1 Polymorphisms As Biomarker Candidates for Slow Atorvastatin Metabolizers." BMC Cancer 2016.